Abstract: The addition of either carbachol or muscarinic agonists to cultured bovine adrenal chromafh cells results in a selective stimulation of phosphatidate (PhA) and phosphatidylinositol (PhI) labeling from 32P, and [3H]glycerol that can be inhibited by the inclusion of atropine, but not d-tubocurarine. In contrast, increased catecholamine secretion is observed on the addition of carbachol or nicotinic agonists and is inhibited by d-tubocurarine but not by atropine. Added calcium is essential for catecholamine secretion but not for stimulated phospholipid labeling. Chelation of endogenous Ca2+ with EGTA does, however, inhibit the stimulated phospholipid labeling. These results suggest that stimulated phospholipid labeling in the bovine chromaffin cell and catecholamine secretion are separate and distinct processes. 
In many tissues cholinergic agonists interact with their specific cell membrane receptors and selectively enhance the labeling of two quantitatively minor phospholipids, phosphatidate (PhA) and phosphatidylinositol (PhI) (Hokin and Hokin, 1953; Schacht and Agranoff, 1972; Michell, 1975; Hawthorne and Pickard, 1979) . There is a broad heterogeneity in the details of the response, and while labeling patterns reflect primarily changes in turnover, altered chemical amounts of these lipids have also been observed (Michell, 1975) . In tissues such as the pancreas, parotid gland, anterior pituitary, guinea pig adrenal medulla, or avian salt gland, the activation of cholinergic muscarinic receptors leads to both a characteristic secretory response and an increased labeling of PhA and/or PhI from added [32P]orthophosphate (Hokin et al., 1958; Hokin and Hokin, 1967; Hokin, 1968; Oron et al., 1975; Young et al., 1979) . Although a role for stimulated phospholipid labeling in the secretory response has been suggested on the basis of such studies, differences in time courses and in requirements for extracellular calcium in various tissues are difficult to reconcile. Thus, despite extensive investigation, the physiological significance of the phospholipid labeling effect remains unknown.
In earlier studies, Trifaro (1969u,b) concluded that acetylcholine-stimulated phospholipid labeling and catecholamine secretion in slices of bovine adrenal medulla were unrelated events. In the adrenal of this species, however, cholinergic receptors coupled to catecholamine secretion appear to be entirely nicotinic (Douglas, 1975) , whereas in all tissues examined to date, cholinergic agoniststimulated phospholipid labeling is mediated by muscarinic and not by nicotinic receptors (Michell, 
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1975).
A recent study indicated the presence of a small number of muscarinic receptors in bovine adrenal medulla (Kayaalp and Neff, 1979 (Kilpatrick et al., 1980; Trifaro and Lee, 1980) . Thus, they provide a useful experimental system in which these questions can be directly addressed with specific biochemical and pharmacological probes.
MATERIALS A N D METHODS
32P1 (carrier-free) and 2j3H]glycerol (0.5 Cilmol) were obtained from Amersham, Chicago, Illinois. "CaCI, (37.4 Ci/g atom) was obtained from New England Nuclear, Boston, Massachusetts. Eagle's minimum essential medium (MEM) and fetal calf serum were obtained from GIBCO, Grand Island, New York. 5-Fluorodeoxyuridine, atropine, d-tubocurarine, bethanechol, muscarine, methacholine, nicotine, and l,l-dimethyl-4-phenyl piperazinium iodide (DMPP) were obtained from Sigma Chemical Co., St. Louis, Missouri. Fungizone was obtained from Squibb, Princeton, New Jersey. Gentamycin was purchased from Microbiological Associates, Bethesda, Maryland.
Chromaffin cells, disaggregated from bovine adrenal medulla, were added to 16-mm diameter uncoated culture wells (approximately 450,000 celldwell) containing 1 ml of MEM medium supplemented with 10% heatinactivated fetal calf serum, 10 p~~5-fluorodeoxyuridine (to inhibit cell division and fibroblast proliferation), 50 p d m l gentamycin, and 2.5 p g m l Fungizone (Fenwick et al., 1978; Livett et al., 1979) . After 2-28 days at 34°C in 5% co2-95% air, chromafEn cells formed monolayers that contained 6-15 nmol catecholamine/well. In some preparations, a Percoll gradient was employed to purify further the chromaffin cells (Kilpatrick et al., 1980) , but since there was no apparent effect on experimental results, this step was discontinued. Secretion and phospholipid labeling experiments were performed at 25°C in a physiological salt solution (PSS) containing 142 mM-NaC1,5.6 mM-KCI, 3.6 mM-NaHCO,, 2.2 mM-CaCl,, 5.6 mM-giucose, 0.1 mg/ml sodium ascorbate, and 15 mM-HEPES buffer (pH 7.4). In secretion experiments, after incubation in test solutions, the contents of the well were added to a test tube containing 56 pI of 50% trichloroacetic acid (TCA). One milliliter of 5% TCA was added to the well and the floor of the well scraped to liberate catecholamine remaining in the cells. Catecholamines (norepinephrine + epinephrine) released into the medium and in the extract of cells was measured by the method of Euler and Floding (1955) . Data are expressed as the percent of the total catecholamine released into the medium at the end of the 15-min incubation. 45Caz+ influx was measured by incubating the cells in PSS containing 45CaCIz (0.5 pCi/assay). After 5 min incubation, the radioactive medium was aspirated and cells washed twice with 1 ml of unlabeled PSS. Triton X-100, 1% (0.5 ml), was then added to each well, cells scraped, and radioactivity counted after the addition of 10 ml of ACS scintillation counting solution (Amersham, Chicago, Illinois).
In phospholipid labeling experiments, the chromaffin cells were allowed to preincubate for 30 min in PSS containing 15-50 pCi 32Pi and 15-25 pCi [3H]glycerol. After preincubation, either 0.5 ml of 5% TCA was added to terminate the labeling (zero-time point, CJ, or, alternatively, the radioactive medium in the wells as aspirated and replaced with either fresh radioactive medium (C,) or fresh radioactive medium containing drug(s) (E). Unless otherwise indicated the C1 and E incubations continued at 25°C for an additional 15 min, after which reactions were terminated by aspiration of the test solution followed by rapid addition of 0.5 ml of 5% TCA. Cells were scraped off the bottom of the well and transferred to test tubes with an additional 1 ml of 5% TCA. Carrier tissue (approximately 10 mg wet wt. of adrenal medulla homogenates) was then added to each tube and allowed to precipitate for 1 h. The precipitated pellets were obtained after low-speed centrifugation, washed with 2 ml of cold distilled water, and the centrifugation step repeated. After aspiration of the supernatant medium, 0.5 ml of water was added to each pellet. Lipids were extracted from the pellets with acidified chloroform-methanol, separated by TLC, and quantitated as previously described (Fisher and Agranoff, 1980) . In some experiments the phospholipids were also separated by two-dimensional TLC (Marggraf, 1976; Yavin and Zutra, 1977) . Three to five wells were analyzed separately for each experimental group. The results are expressed as percent stimulation of labeling relative to controls, calculated from the formula, E -CJ C, -Co x 100%. Data are expressed as mean c S.E.M.
Statistical significance was determined by a two-tailed Student's t-test.
RESULTS
Chromaffin cells preincubated with 32P, and
[3H]glycerol incorporated both labeled precursors into several phospholipids, including PhA, PhI, phosphatidylethanolamine, phosphatidylcholine, a n d t h e polyphosphoinositides (phosphatidylinositol phosphate and -diphosphate). The relative amounts of radioactivity in each phospholipid varied somewhat with the chromaffh cell preparation and the age of culture. Irrespective of the basal (unstimulated) labeling pattern, the addition of carbachol consistently induced a selective stimulation of incorporation of both 32Pi and
[3H]glycerol into PhA and PhI, which was evident at 2-5 min of incubation (Fig. 1) The corresponding values for PhI stimulation were 220 ? 34% and 197% 24%. On no occasion did the addition of carbachol to the cultures induce a statistically significant increase in the incorporation of either s2Pi or [3H ]glycerol into phosphatidylethanolamine, lysophosphatidylethanolamink, or the polyphosphoinositides, although occasionally phosphatidylcholine labeling was also stimulated, especially in prolonged incubations. Lyso PhA was detected in some preparations and its identity verified by twodimensional TLC. When present, its labeling was stimulated to the same extent as PhA by addition of carbachol. There was no detectable labeling of lysophosphatidylcholine in either control or carbachol-treated cultures. To determine whether the catecholamines liberated from the cells by the addition of carbachol were responsible for the stimulation of labeling, a mixture of 20 p~-epinephrine and 20 pM-norepinephrine (5-10 times the concentration of catecholamine usually liberated into the medium) was added to the cells. No stimulation of either 32Pi or [3H]glycerol incorporation into phospholipids occurred (93-96% of control), indicating that the released neurohumors were not directly responsible for the stimulation of phospholipid labeling.
To determine whether the activation of muscarinic or of nicotinic receptors was responsible for the observed changes in phospholipid labeling, a series of experiments was performed using specific agonists and antagonists. Only muscarinic agonists such as muscarine and methacholine (3 x 1 0 -4~) were as effective as carbachol (see above) in the stimulation of PhA and PhI labeling ( Table 1) . As in the case of carbachol, the addition of muscarinic agonists resulted in an enhanced incorporation of both 32Pi and [3H]glycerol, indicating an increased de novo synthesis of these lipids. Of the nicotinic agonists tested, the addition of nicotine or DMPP at concentrations optimal for catecholamine secretion (lo-5 M) had little or no effect on phospholipid labeling. The addition of higher concentrations of nicotine or DMPP (3 x M) also failed to alter lipid labeling. In contrast, the secretion of catecholamines from chromafin cells occurred to the same magnitude in the presence of nicotinic agonists ( 10-s M) or carbachol (3 x M), whereas muscarinic agonists such as muscarine, methacholine, and bethanechol (3 x M) had no effect ( Table 1) . Further evidence for a different pharmacological specificity of stimulated phospholipid labeling and catecholamine secretion was obtained from experiments with muscarinic and nicotinic antagonists. Carbachol-stimulated labeling of both PhA and PhI was fully reversed by inclusion of M-atropine, whereas the addition of a 40-fold higher concentration of d-tubocurarine (4 x 10-5 M) had no statistically significant effect on stimulated labeling. In contrast, the secretion of catecholamines was unaffected by M-atropine, but was inhibited by more than 65% by the addition of 4 x lo-' ~-dtubocurarine (Table 1) . Both carbachol-stimulated phospholipid labeling and catecholamine secretion were dependent on the availability of calcium, but in different ways. The omission of calcium from PSS resulted in an increase in the basal (unstimulated) labeling of PhI, and in a variable increase in that of PhA. The car- For phospholipid labeling, chromafin cell cultures were preincubated for 30 min at 25°C in PSS containing 25-45 pCi 32P,. After preincubation, the radioactive medium was aspirated and replaced with fresh radioactive medium with or without drugs. Results are expressed as 32P, incorporated into PhA and PhI during the 15-min incubation period (3-5 wells/group) and the percentage stimulation of labeling relative to control is indicated in parentheses. Neither d-tubocurarine nor atropine had any significant effect on phospholipid labeling when added alone. Results from two separate experiments are shown. Three additional experiments gave essentially similar results. Catecholamine release was measured over a 15-rnin period in the presence or absence of drugs as indicated (3 wells/group). Calcium influx was measured over a 5-min period (3 welldgroup). Final concentrations of agonists and antagonists were as follows (M): carbachol (3 x lo-'); muscarine (3 x lo-'): methacholine (3 x lo-'): bethanechol(3 x lo-'): nicotine DMPP atropine d-tubocurarine
Different from control, " P < 0.005; P < 0.02; P < 0.01: different from carbachol-(4 x 10-5).
treated, P < 0.02.
bachol stimulation of phospholipid labeling was only minimally reduced by the omission of calcium, but was severely inhibited by the presence of EGTA (Fig. 2) . In contrast, catecholamine secretion showed an absolute dependence on the presence of calcium in the medium, and could not be detected either in the absence of added calcium or in the presence of EGTA (Fig. 2) . Whereas the addition of carbachol or nicotine resulted in a 40-80% stimulation of 45Ca2+ influx into chromaffin cells, muscarinic agonists had no measurable effect (Table 1) . Further evidence to dissociate the phospholipid labeling effect from secretion was obtained in experiments in which elevation of extracellular K+ concentrations by substitution of the standard incubation medium containing 5.6 mM-K+ and 142 mM-Na+ with one containing 56 mM-K+ and 92 mM-Na+ resulted in an induction of catecholamine release (14 c 1% of total cell catecholamine content, P < 0.001), but had no significant effect on the incorporation of either 32Pi or [3H]glycerol into PhA or PhI (93-114% of control).
DISCUSSION
The present study indicates a pharmacological distinction between the secretory response of bovine chromaffin cell preparations, which is mediated only through nicotinic cholinergic receptors, and stimulated phospholipid labeling, which, as in other tissues, is linked to muscarinic cholinergic receptors (Michell, 1975; Hawthorne and Pickard, 1979; Fisher and Agranoff, 1980) . Thus in this experimental preparation, stimulated phospholipid labeling appears to be neither a prerequisite for nor a consequence of secretion.
In addition to differences in pharmacological specificity, separate roles for calcium in catecholamine secretion and phospholipid labeling also distinguish the two processes. The addition of EGTA to a calcium-free medium was required to reduce stimulated phospholipid labeling 75 -85%, whereas a calcium-free medium alone caused little inhibition. In contrast, catecholamine secretion was completely inhibited in the Ca2+-free medium in the absence of EGTA. The effect of EGTA on stimulated phospholipid labeling may result from removal of tightly bound Ca2+ from the cell surface or by acceleration of loss of intracellular Ca*+. The finding that conditions for muscarinic stimulation of phospholipid labeling did not result in a measurable stimulation of 45Ca2+ influx into the cells whereas nicotinic agents did supports the view that medium calcium enters the cell during nicotinic stimulation to induce exocytosis and further supports the premise that the muscarinic receptor is not coupled to the enhancement of catecholamine secretion.
The conclusion that catecholamine secretion and stimulated phospholipid labeling are not correlated is in agreement with an earlier study by Trifaro  (1969a,b) , who used bovine adrenal medulla slices. Although no pharmacological differentiation was made in that study, a distinction between the two processes was inferred on the basis of their respective time courses and the effects of calcium omission. The results obtained with the chromaffin cell culture in the present study differ, however, from those obtained with slices in several aspects. First, the stimulation of PhA and PhI labeling in chromaffin cells is considerably more rapid than that observed in slices, presumably as a result of rapid exposure of receptors on cultured cells to the ligand. Thus, stimulated PhA and PhI labeling was detected as early as 1 min after carbachol addition to the chromaffin cell preparation, compared with 10-20 min in the adrenal medulla slices. Since catecholamine secretion from the chromaffin cells also begins within 1 min of the addition of carbachol (Holz, unpublished observations), a temporal distinction between the onset of stimulated phospholipid labeling and the onset of catecholamine secretion cannot be made. Second, the carbachol-me-diated increase in 32Pi incorporation into PhA and PhI in chromaffin cells is at least partly the result of increased de novo phospholipid synthesis, since incorporation of [3H]glycerol is increased. In the slice experiments, only 32P labeling was stimulated (Trifaro, 1969~). Third, while we confirm a calcium requirement for catecholamine secretion, the present results indicate, in contrast to the conclusions of Trifaro, that calcium may also play an important role in stimulated phospholipid labeling of chromaffin cells, as has been shown previously for the muscarinic stimulation of phospholipid labeling in synaptosomes (Fisher and Agranoff, 1980) and iris smooth muscle (Akhtar and Abdel-Latif, 1978) .
The question arises as to whether the muscarinic phospholipid labeling effect could not result from contaminating adrenal cortical cells that are inevitably present in chromaffin cell preparations (Kilpatrick et al., 1980) . Adrenal cortical cell preparations support a phospholipid labeling effect in the presence of carbachol (data not shown) and there is some evidence for the presence of intrinsic muscarinic receptors (N. H. Neff, personal communication). However, significantly greater amounts of receptors are found in the adrenal medulla (Kayaalp and Neff, 1979) . Further indications for the presence of intrinsic muscarinic receptors in chromaffin cells derive from studies on the elevation by muscarinic agents of cellular cGMP levels in chromaffin cells (Schneider et al., 1979; Lemaire et al., 1980) . Kilpatrick et al. (1980) have provided histological evidence that young primary cultures of chromaffin cells were approximately 10% contaminated with adrenal cortical cells. This value increases with the age of the culture, since the latter cells have superior survival properties. In the present study, however, there was no indication of an increase in the phospholipid labeling effect as either a function of culture age or following cell purification on a Percoll gradient, findings that further argue against the possibility that the observed stimulation of labeling is mediated by adrenal cortical rather than by chromaffin cells.
The present findings then confirm in cultured chromaffin cells the muscarinic nature of the cholinergic phospholipid labeling effect and distinguish it from the nicotinic receptor-mediated exocytotic release of catecholamines.
